Peri-operative Aspirin Continuation Versus Discontinuation
Status:
Terminated
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
This study evaluates the continuation (non-discontinuation) of Aspirin during TURBT. Half of
participants will continue their usual low-dose Aspirin regimen during TURBT and throughout
the perioperative period, while the other half will discontinue Aspirin use ten days prior to
surgery (standard recommendation) and restart therapy two weeks post-discharge.